I had the pleasure of interviewing Eric Verdin, CEO and President of the Buck Institute for Research on Aging in California, during the Rejuvenation Startup Summit.
Eric shared fascinating insights into how we can bring aging research from animal models to human applications, focusing on safety and efficacy. He emphasized the importance of startups in this field and how they are creating a community to push the boundaries of longevity science. 💡🔬
Key Discussion Points:
- Startups and Market Potential: Differentiating between companies pursuing classical drug routes with stringent regulatory paths and those focusing on supplements with lower regulatory barriers.
Supplement Route: How supplements can reach the market faster, although proving their efficacy remains a challenge.
- Innovative Approaches: The potential for new combinations of existing drugs to create patentable and effective treatments.
- Intrinsic Aging Clock: Development of new tools like the Intran Clock to measure true biological aging without interference from external factors like infections.
- Personal Recommendations: Insights into supplements that could support longevity, such as omega fatty acids, vitamin D, vitamin B12, and creatine.
This interview offers deep insights into the current state and future potential of longevity research and biotech innovation. Don’t miss the chance to listen to this inspiring conversation! 🎧🔊